Nephrotoxicity of conventional chemotherapeutics: part 1—platinum compounds and antimetabolite agents
Nephrology Dialysis Transplantation · 2026
DOI: 10.1093/ndt/gfaf251 ↗Kurz gefasst
Übersichtsarbeit in der Zeitschrift Nephrology Dialysis Transplantation, 2026. Verfasst von Adam Kelly und 20 weiteren Autor:innen. Beteiligte Einrichtung: Division of Nephrology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA. Hauptthemen laut MEDLINE: Antineoplastic Agents, Platinum Compounds, Neoplasms, Antimetabolites, Antineoplastic. Die Arbeit wurde bisher 3-mal zitiert (Crossref) und nennt 56 Literaturangaben.
Abstract (Originalsprache)
Anticancer therapies have significantly improved survival rates in patients with cancer; however, despite prophylactic measures, many conventional chemotherapeutic agents cause acute and chronic kidney injury. This review provides a comprehensive analysis of the incidence, characteristics and management of platinum-based and antimetabolite chemotherapeutic agent–associated nephrotoxicity based on the existing literature. Understanding the profiles of these onconephrotoxic agents is essential for optimizing anticancer treatment while minimizing kidney complications.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Division of Nephrology, Department of Medicine, Medical College of Wisconsin, Milwaukee, WI, USA.
- Department of Nephrology, Vardhman Mahavir Medical College and Safdarjung Hospital, New Delhi, India.
- MD Anderson Cancer Center, University of Texas, Houston, TX, USA.
- Specialized Universal Network of Oncology Center, Alexandria, Egypt.
- Division of Renal Medicine, Department of Medicine, Brigham and Women's Hospital, Boston, MA, USA.
- Dana Farber Cancer Institute, Boston, MA, USA.
ORCID-Profile: Shruti Gupta, Marco Bonilla, Kenar D Jhaveri, Paul E Hanna
Zitieren
APA
Kelly, A., Sharma, S., Mamlouk, O., Hassanein, M., Chowdhury, R., Gupta, S., Troung, H., Bonilla, M., Kalra, K., Wanchoo, R., Pariswala, T., Turcotte, A. E., Zaveri, I., Dernell, C., Ibrahim, M., Patel, M., Eskander, S. S., Gudsoorkar, P., Jhaveri, K. D., …, & Hanna, P. E. (2026). Nephrotoxicity of conventional chemotherapeutics: part 1—platinum compounds and antimetabolite agents. Nephrology Dialysis Transplantation. https://doi.org/10.1093/ndt/gfaf251
Vancouver
Kelly A, Sharma S, Mamlouk O, Hassanein M, Chowdhury R, Gupta S, et al. Nephrotoxicity of conventional chemotherapeutics: part 1—platinum compounds and antimetabolite agents. Nephrology Dialysis Transplantation. 2026. doi:10.1093/ndt/gfaf251
BibTeX
@article{Kelly2026,
author = {Kelly, Adam and Sharma, Sourabh and Mamlouk, Omar and Hassanein, Mohamed and Chowdhury, Raad and Gupta, Shruti and Troung, Heather and Bonilla, Marco and Kalra, Kartik and Wanchoo, Rimda and Pariswala, Tanazul and Turcotte, Anna-Eve and Zaveri, Ishaan and Dernell, Carl and Ibrahim, Mohamed and Patel, Maulinkumar and Eskander, Sylvia S and Gudsoorkar, Prakash and Jhaveri, Kenar D and Perazella, Mark A and Hanna, Paul E},
title = {Nephrotoxicity of conventional chemotherapeutics: part 1—platinum compounds and antimetabolite agents},
journal = {Nephrology Dialysis Transplantation},
year = {2026},
doi = {10.1093/ndt/gfaf251}
}
EUVIMED